大唐電信(600198.SH):大唐半導體辦理完畢電信科研院債轉股增資的工商變更登記
格隆匯12月23日丨大唐電信(600198.SH)公佈,公司將其對電信科學技術研究院有限公司(以下簡稱“電信科研院”)的18.17億元的債務轉讓給大唐半導體設計有限公司(以下簡稱“大唐半導體”),電信科研院以前述對大唐半導體的債權以非公開協議方式對大唐半導體增資18.17億元。
2019年12月19日,經北京市海淀區市場監督管理局核准,大唐半導體辦理完畢電信科研院債轉股增資的工商變更登記,並取得換髮後的《營業執照》。本次工商變更登記後,電信科研院所持有大唐半導體49.22%的股權,大唐電信持有大唐半導體50.78%的股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.